Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-11-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.649244PMID 17060376
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.

  2005cited by this paper
• Infarct-Sparing Effect of A2A-Adenosine Receptor Activation Is Due Primarily to Its Action on Lymphocytes

  2005cited by this paper
• Adenosine in Tissue Protection and Tissue Regeneration

  2005cited by this paper
• A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells1

  2005cited by this paper
• Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide.

  2004cited by this paper
• T-lymphocytes modulate the microvascular and inflammatory responses to intestinal ischemia-reperfusion.

  2002cited by this paper
• Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.

  2002cited by this paper
• T‐Lymphocytes Modulate the Microvascular and Inflammatory Responses to Intestinal Ischemia‐Reperfusion

  2002cited by this paper
• Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium.

  2001cited by this paper
• Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

  2001cited by this paper
• Interplay of antibody and T cell responses in acute myocardial infarction.

  2001cited by this paper
• The immune response following myocardial infarction: a role for T-cell-mediated myocyte damage.

  2000cited by this paper
• Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice.

  2000cited by this paper
• Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.

  2000cited by this paper
• Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies.

  1999cited by this paper
• Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats.

  1999cited by this paper
• RANTES-induced T cell activation correlates with CD3 expression.

  1998cited by this paper
• T helper 1 and T helper 2 cells respond differentially to chemokines.

  1998cited by this paper
• Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion.

  1997cited by this paper
• CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.

  1997cited by this paper
• The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.

  1997cited by this paper
• Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.

  1997cited by this paper
• Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells*

  1997cited by this paper
• Myocardial ischemia alters immunoregulatory cell traffic and function in the rat independent of exogenous catecholamine administration.

  1996cited by this paper
• Incremental Value of the Leukocyte Differential and the Rapid Creatine Kinase-MB Isoenzyme for the Early Diagnosis of Myocardial Infarction

  1995cited by this paper
• Cytokine mRNA expression in postischemic/reperfused myocardium.

  1995cited by this paper
• Monocyte chemotactic proteins MCP‐1, MCP‐2, and MCP‐3 are major attractants for human CD4+ and CD8+ T lymphocytes

  1994cited by this paper
• Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction.

  1994cited by this paper
• Mechanisms of immune-mediated myocyte injury.

  1994cited by this paper
• Immunological aspects in patients with acute myocardial infarction.

  1993cited by this paper
• Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence.

  1992cited by this paper
• Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

  1991cited by this paper
• Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation.

  1986cited by this paper

• From Single Cells to Targetable Immune Mechanisms in Congenital Heart Disease, Ischemic Heart Disease, and Abdominal Aortic Aneurysm.

  2026cites this paper
• Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses.

  2026cites this paper
• Enhanced neoangiogenesis and balance of the immune response mediated by the Wilms' tumor suppressor WT1 favor repair after myocardial infarction

  2025cites this paper
• Adaptive Immunity in Immunothrombosis

  2025cites this paper
• T-regulatory cell protection of progenitor cells from CD4+ T-cell-mediated cytotoxicity is essential for endogenous mouse digit-tip regeneration

  2025cites this paper
• The Research Progress of T Lymphocytes in Myocardial Infarction.

  2025cites this paper
• Cardiovascular inflammaging: Mechanisms, consequences, and therapeutic perspectives

  2025cites this paper
• T cells in cardiovascular disease: solved and unsolved mysteries

  2025cites this paper
• Sex differences in the chronic autoimmune response to myocardial infarction

  2025cites this paper
• Harnessing mRNA for heart health: a new era in cardiovascular treatment

  2025cites this paper
• Postoperative Adenosine Deaminase Activity Predicts Complications After On-Pump Cardiac Surgery.

  2025cites this paper
• Mechanisms of mitochondrial damage-associated molecular patterns associated with inflammatory response in cardiovascular diseases

  2025cites this paper
• CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion

  2025cites this paper
• Humanized Monoclonal Antibody Against Citrullinated Histone H3 Attenuates Myocardial Injury and Prevents Heart Failure in Rodent Models

  2025cites this paper
• Myocardial oxygen handling and metabolic function of ex-situ perfused human hearts from circulatory death donors

  2024cites this paper
• The roles of Th cells in myocardial infarction

  2024cites this paper
• Adenosine 2A Receptor Agonism Improves Survival in Extracorporeal Cardiopulmonary Resuscitation.

  2024cites this paper
• Consensus Clustering Analysis Identifies Ferroptosis-Related Patient Clusters and Predictive Signature Construction Based on Ferroptosis-Related Genes in Ischemic Cardiomyopathy

  2024cites this paper
• Targeting the adaptive immune continuum in atherosclerosis and post-MI injury.

  2024cites this paper
• Interleukin-12p40 deficiency attenuates myocardial ferroptosis in doxorubicin-induced chronic cardiomyopathy by inhibiting Th17 differentiation and interleukin-17A production.

  2024cites this paper
• CAR‐T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives

  2024cites this paper
• Macrophages coordinate immune response to laser-induced injury via extracellular traps

  2024cites this paper
• Translational Experimental Basis of Indirect Adenosine Receptor Agonist Stimulation for Bone Regeneration: A Review

  2024cites this paper
• Integrated bioinformatics and machine learning algorithms reveal the unfolded protein response pathways and immune infiltration in acute myocardial infarction

  2024cites this paper
• Serotonin Receptors in Myocardial Infarction: Friend or Foe?

  2024cites this paper
• Targeting regulatory T cells for cardiovascular diseases

  2023cites this paper
• Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease

  2023cites this paper
• Impact of Reperfusion on Temporal Immune Cell Dynamics After Myocardial Infarction.

  2023cites this paper
• Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation

  2023cites this paper
• Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential

  2023cites this paper
• Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion

  2023cites this paper
• The interplay between T lymphocytes and macrophages in myocardial ischemia/reperfusion injury

  2023cites this paper
• Associations of systemic inflammation markers with myocardial enzymes in pediatric adenotonsillar hypertrophy: A cross-sectional study

  2023cites this paper
• Identification of potential biomarkers associated with CD4+ T cell infiltration in myocardial ischemia-reperfusion injury using bioinformation analysis

  2023cites this paper
• Regulation of cardiac fibroblasts by lymphocytes after a myocardial infarction: Playing in the Major League.

  2023cites this paper
• Identification of shared fatty acid metabolism related signatures in dilated cardiomyopathy and myocardial infarction

  2023cites this paper
• Myocardial regeneration and the enigma of the immune cells.

  2023cites this paper
• Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction

  2023cites this paper
• T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade

  2023cites this paper
• β-catenin ameliorates myocardial infarction by preventing YAP-associated apoptosis

  2023cites this paper
• Participation of ASK-1 in the cardiomyocyte-protective role of mechanical ventilation in a rat model of myocardial infarction

  2023cites this paper
• Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated

  2023cites this paper
• Interplay of hypoxia-inducible factors and oxygen therapy in cardiovascular medicine

  2023cites this paper
• The role of Vav3 expression for inflammation and cell death during experimental myocardial infarction

  2023cites this paper
• Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling

  2023cites this paper
• Leukocyte-Mediated Cardiac Repair after Myocardial Infarction in Non-Regenerative vs. Regenerative Systems

  2022cites this paper
• Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms

  2022influential citation
• HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction

  2022cites this paper
• Myeloid cell-specific ablation of Runx2 gene exacerbates post-infarct cardiac remodeling

  2022cites this paper
• Hyaluronan Synthase 3 is Protective After Cardiac Ischemia-Reperfusion by preserving the T cell Response.

  2022cites this paper
• Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction

  2022cites this paper
• Topical Neck Cooling Without Systemic Hypothermia Attenuates Myocardial Ischemic Injury and Post-ischemic Reperfusion Injury

  2022cites this paper
• Signaling cascades in the failing heart and emerging therapeutic strategies

  2022cites this paper
• Alternative adenosine Receptor activation: The netrin-Adora2b link

  2022cites this paper
• The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction

  2022cites this paper
• Adenosine A2a Receptor Regulates Autophagy Flux and Apoptosis to Alleviate Ischemia-Reperfusion Injury via the cAMP/PKA Signaling Pathway

  2022cites this paper
• The why and how of adaptive immune responses in ischemic cardiovascular disease

  2022cites this paper
• Device‐Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies

  2022cites this paper
• The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury

  2022cites this paper
• Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway

  2021cites this paper
• Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair

  2021cites this paper
• Influence of pentoxifylline on gene expression of PAG1/ miR-1206/ SNHG14 in ischemic heart disease

  2021cites this paper
• Inflammatory Cell Recruitment in Cardiovascular Disease

  2021cites this paper
• Lymphatic Clearance of Immune Cells in Cardiovascular Disease

  2021cites this paper
• Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions

  2021cites this paper
• Plasmacytoid Dendritic Cells Mediate Myocardial Ischemia/Reperfusion Injury by Secreting Type I Interferons

  2021cites this paper
• Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction

  2021cites this paper
• Epoxyeicosatrienoic Acids Prevent Cardiomyocytes against Sepsis by A2AR-induced Activation of PI3K and PPARγ.

  2021cites this paper
• From Autonomy to Integration, From Integration to Dynamically Balanced Integrated Co-existence: Non-aging as the Third Stage of Development

  2021cites this paper
• Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction

  2021cites this paper
• Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms

  2021cites this paper
• Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction

  2021cites this paper
• Interactions Between Adenosine Receptors and Cordycepin (3'- Deoxyadenosine) from Cordyceps Militaris: Possible Pharmacological Mechanisms for Protection of the Brain and the Amelioration of Covid-19 Pneumonia

  2021cites this paper
• Polydeoxyribonucleotide Regulation of Inflammation

  2020cites this paper
• Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction

  2020cites this paper
• Myocardial ischemic reperfusion injury – A review

  2020cites this paper
• New Approaches to Target Inflammation in Heart Failure: Harnessing Insights from Studies of Immune Cell Diversity.

  2020cites this paper
• Design and Rationale of the ERA-CVD Consortium PREMED-CAD—Precision Medicine in Coronary Artery Disease

  2020cites this paper
• Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair

  2020cites this paper
• Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy

  2020cites this paper
• Adenosine A2A receptor agonist (regadenoson) in human lung transplantation.

  2020cites this paper
• Zebrafish cardiac regeneration—looking beyond cardiomyocytes to a complex microenvironment

  2020cites this paper
• Cardiac Cellularity is Dependent upon Biological Sex and is Regulated by Gonadal Hormones.

  2020cites this paper
• Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction

  2020cites this paper
• The Regulatory Role of T Cell Responses in Cardiac Remodeling Following Myocardial Infarction

  2020cites this paper
• CD73 expression is critical to therapeutic effects of human endometrial regenerative cells in inhibition of cardiac allograft rejection in mice

  2020cites this paper
• Recombinant Human Brain Natriuretic Peptide Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting CD4+ T Cell Proliferation via PI3K/AKT/mTOR Pathway Activation

  2020cites this paper
• Adult T-cells impair neonatal cardiac regeneration

  2020cites this paper
• Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling

  2020cites this paper
• Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease.

  2020cites this paper
• The Role of Arachidonic Acid Metabolism in Myocardial Ischemia–Reperfusion Injury

  2020cites this paper
• A novel small molecule compound VCP979 improves ventricular remodeling in murine models of myocardial ischemia/reperfusion injury

  2019cites this paper
• Role of fingolimod in cardioprotection

  2019cites this paper
• Dynamic Profile of CD4+ T-Cell-Associated Cytokines/Chemokines following Murine Myocardial Infarction/Reperfusion

  2019cites this paper
• Keeping our hearts "NEAT"?

  2019cites this paper
• Cardiac Remodeling: The Course Toward Heart Failure – I. General Concepts

  2019cites this paper
• Immune Disorder in Atherosclerotic Cardiovascular Disease　- Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers.

  2019cites this paper
• Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling

  2019cites this paper
• T-cell activation and cardiovascular risk in adults with type 2 diabetes mellitus: A systematic review and meta-analysis.

  2019cites this paper
• Lymphocytic subsets play distinct roles in heart diseases

  2019cites this paper